GGrantIndex
← Leaderboards

Joseph Edward Willis

Case Western Reserve University

$7,788,271
Attributed
$12,414,815
Total exposure
14
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,614,290 · 15

By mechanism

P50$4,580,332 · 4
U01$3,074,039 · 1
R01$1,623,261 · 1
UH2$664,284 · 1
UH3$653,230 · 1
U54$598,706 · 3

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Technology

Research focus

TechnologyMolecularTissuesMalignant NeoplasmsLinkSpecimenSamplingMedical CenterProspectiveFollow-UpPathologyLaboratoriesColon CarcinomaImmunohistochemistryFacultyProgramsSuccessBaseUniversity HospitalsInsightParaffin EmbeddingBarrett EsophagusFormalinResources

Grant awards (41)

A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression$1,623,261
R01 · FY2025 · CA
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation$1,048,823
U01 · FY2025 · CA
Bioreagents & Resources Core$186,036
P01 · FY2025 · CA · contact PI
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation$996,868
U01 · FY2024 · CA
Bioreagents & Resources Core$176,733
P01 · FY2024 · CA · contact PI
Pathology Core$64,650
U54 · FY2024 · CA · contact PI
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation$1,028,348
U01 · FY2023 · CA
Bioreagents & Resources Core$186,034
P01 · FY2023 · CA · contact PI
Pathology Core$71,089
U54 · FY2023 · CA · contact PI
Pathology Core$64,650
U54 · FY2022 · CA · contact PI
Patients Registry -Virtual Biorepository Core$290,457
U54 · FY2021 · CA · contact PI
Core 1: Biospecimen Core$232,501
P50 · FY2021 · CA · contact PI
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers$232,500
P50 · FY2021 · CA · contact PI
Pathology Core$52,870
U54 · FY2021 · CA · contact PI
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers$362,917
P50 · FY2020 · CA · contact PI
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus$332,184
UH3 · FY2020 · CA · contact PI
Core 1: Biospecimen Core$132,563
P50 · FY2020 · CA · contact PI
Biospecimen/Pathology Core$100,223
P20 · FY2020 · CA · contact PI
Pathology Core$54,990
U54 · FY2020 · CA · contact PI
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers$373,975
P50 · FY2019 · CA · contact PI
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus$321,046
UH3 · FY2019 · CA · contact PI
Core 1: Biospecimen Core$150,451
P50 · FY2019 · CA · contact PI
Biospecimen/Pathology Core$96,714
P20 · FY2019 · CA · contact PI
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers$401,748
P50 · FY2018 · CA · contact PI
Core 1: Biospecimen Core$161,733
P50 · FY2018 · CA · contact PI
Biospecimen/Pathology Core$99,600
P20 · FY2018 · CA · contact PI
Project 2: Translational Significance of a Mutational Signature of African American Colon Cancers$413,248
P50 · FY2017 · CA · contact PI
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus$317,889
UH2 · FY2017 · CA · contact PI
Core 1: Biospecimen Core$153,354
P50 · FY2017 · CA · contact PI
Validation of Methylated Vimentin as a Diagnostic Test for Barrett's Esophagus$346,395
UH2 · FY2016 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$306,209
P50 · FY2015 · CA · contact PI
Biospecimen$197,587
P50 · FY2015 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$301,405
P50 · FY2014 · CA · contact PI
Biospecimen$196,164
P50 · FY2014 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$308,257
P50 · FY2013 · CA · contact PI
Biospecimen$163,357
P50 · FY2013 · CA · contact PI
Identifying Mutational Drivers of Late Stage Colon Cancer$316,595
P50 · FY2012 · CA · contact PI
Biospecimen$175,768
P50 · FY2012 · CA · contact PI
Identification of Significant Race Associated Colon Cancer Drive Gene Mutations$102,443
R21 · FY2012 · CA · contact PI
Identification of Significant Race Associated Colon Cancer Drive Gene Mutations$273,180
R21 · FY2011 · CA · contact PI
Laser Capture Microdissection Instrument$199,475
S10 · FY2005 · RR